Impression Healthcare applies for medical cannabis licence
The licenses being pursued will allow Impression, subject to individual product permit issue, the capacity to capitalise on local and international opportunities
The licenses being pursued will allow Impression, subject to individual product permit issue, the capacity to capitalise on local and international opportunities
Medicinal cannabis registries typically report pain as the most common reason for use. It would be clinically useful to identify patterns of cannabis treatment in migraine and headache, as compared to arthritis and chronic pain, and to analyze preferred cannabis strains, biochemical profiles, and prescription medication substitutions with cannabis. Prospective studies are needed, but results may provide early insight into optimizing crossbred cannabis strains, synergistic biochemical profiles, dosing, and patterns of use in the treatment of headache, migraine, and chronic pain syndromes.